The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor...
60 KB (6,879 words) - 14:26, 16 July 2024
Epidermal growth factor (EGF) is a protein that stimulates cell growth and differentiation by binding to its receptor, EGFR. Human EGF is 6-kDa and has...
17 KB (1,708 words) - 22:30, 15 October 2024
HER2 (redirect from Human epidermal growth factor receptor 2)
(human epidermal growth factor receptor 2) or CD340 (cluster of differentiation 340). HER2 is a member of the human epidermal growth factor receptor (HER/EGFR/ERBB)...
43 KB (4,651 words) - 13:41, 27 July 2024
ErbB (redirect from Epidermal growth factor receptor family)
family of proteins contains four receptor tyrosine kinases, structurally related to the epidermal growth factor receptor (EGFR), its first discovered member...
24 KB (2,736 words) - 00:12, 28 November 2023
dominant receptor types that are exclusive to research : the epidermal growth factor receptor, the neurotrophin receptor, and the insulin receptors. All growth...
5 KB (591 words) - 15:41, 29 April 2024
Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. Of the 90...
28 KB (3,078 words) - 07:46, 3 June 2024
TGF alpha (redirect from Transforming growth factor alpha)
receptors capable of protein kinase activity for cellular signaling. TGF-α is a transforming growth factor that is a ligand for the epidermal growth factor...
17 KB (2,112 words) - 08:28, 7 September 2024
Amivantamab is a bispecific epidermal growth factor (EGF) receptor-directed and mesenchymal–epithelial transition (MET) receptor-directed antibody. It is...
24 KB (1,890 words) - 16:21, 4 October 2024
a membrane-anchored mitogenic and chemotactic glycoprotein. An epidermal growth factor produced by monocytes and macrophages, due to an affinity for heparin...
20 KB (2,598 words) - 14:07, 21 July 2024
Breast development (redirect from Growth of the breast)
induce the expression of growth factors, such as amphiregulin, epidermal growth factor (EGF), IGF-1, and fibroblast growth factor (FGF), which in turn have...
59 KB (6,495 words) - 08:42, 1 July 2024
example, epidermal growth factor (EGF) enhances osteogenic differentiation (osteogenesis or bone formation), while fibroblast growth factors and vascular...
10 KB (1,131 words) - 19:14, 31 March 2024
Growth factor receptor inhibitors (growth factor inhibitors, growth factor receptor blockers, growth factor blockers, growth factor receptor antagonists...
4 KB (381 words) - 22:35, 2 December 2023
Erlotinib (category Receptor tyrosine kinase inhibitors)
cancer. Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R)...
22 KB (1,993 words) - 23:37, 23 March 2024
Activation of other growth factor receptors such as fibroblast growth factor receptors or epidermal growth factor receptor can also be responsible. Acanthosis...
18 KB (1,782 words) - 19:54, 17 July 2024
factor, such as Myc. This process is described in more detail below. Receptor-linked tyrosine kinases, such as the epidermal growth factor receptor (EGFR)...
24 KB (3,068 words) - 07:21, 7 June 2024
The insulin-like growth factor 1 (IGF-1) receptor is a protein found on the surface of human cells. It is a transmembrane receptor that is activated by...
29 KB (3,603 words) - 16:26, 25 May 2024
Tyrosine kinase (section Receptor)
cell-surface receptor tyrosine kinase. Kinase inhibitors can also be mediated. Paracrine signalling mediates the response to epidermal growth factor receptor kinase...
43 KB (5,251 words) - 10:44, 24 June 2024
GRB2 (redirect from Growth factor receptor-bound protein 2)
GRB2 gene. The protein encoded by this gene binds receptors such as the epidermal growth factor receptor and contains one SH2 domain and two SH3 domains...
82 KB (9,365 words) - 15:39, 31 March 2024
Osimertinib (category Receptor tyrosine kinase inhibitors)
carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. The most common side effects include...
18 KB (1,573 words) - 05:19, 15 October 2024
ERBB3 (redirect from Receptor, erbb-3)
Receptor tyrosine-protein kinase erbB-3, also known as HER3 (human epidermal growth factor receptor 3), is a membrane bound protein that in humans is...
24 KB (2,816 words) - 06:51, 2 November 2024
Epidermal growth factor receptor kinase substrate 8-like protein 1 is an enzyme that in humans is encoded by the EPS8L1 gene. This gene encodes a protein...
4 KB (447 words) - 20:57, 29 September 2022
Fibroblast growth factor receptor 1 (FGFR-1), also known as basic fibroblast growth factor receptor 1, fms-related tyrosine kinase-2 / Pfeiffer syndrome...
44 KB (5,003 words) - 07:11, 15 October 2024
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal...
26 KB (2,420 words) - 02:40, 26 September 2024
epidermal growth factor, which has a high binding affinity for the epidermal growth factor receptor. As structural domains within larger proteins, GFLD regions...
1 KB (132 words) - 20:57, 11 September 2020
in the United States for people with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer when used in combination...
12 KB (725 words) - 15:37, 8 September 2024
Triple-negative breast cancer (section Risk factors)
or shows low levels of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) overexpression and/or gene...
28 KB (3,411 words) - 03:40, 14 June 2024
Gefitinib (category Receptor tyrosine kinase inhibitors)
inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in...
21 KB (2,162 words) - 15:09, 19 August 2024
description of compounds inhibiting the catalytic activity of the epidermal growth factor receptor (EGFR). The 1988 study was the first demonstration of a systematic...
10 KB (1,179 words) - 18:31, 8 August 2024
Lapatinib (category Receptor tyrosine kinase inhibitors)
tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways. It is used in combination therapy for HER2-positive...
18 KB (1,504 words) - 01:24, 12 October 2024
Afatinib (category Receptor tyrosine kinase inhibitors)
that also irreversibly inhibits human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases. Afatinib is not only...
15 KB (1,122 words) - 15:16, 4 August 2024